An egg white-derived tripeptide called IRW reduced blood pressure by up to 40 mmHg in spontaneously hypertensive rats through ACE inhibition, nitric oxide preservation, and anti-inflammatory effects.
~40 mmHg blood pressure dropHigh-dose IRW reduced mean blood pressure by approximately 40 mmHg in spontaneously hypertensive rats over 18 days
What the researchers found
Oral administration of the egg-derived tripeptide IRW (Ile-Arg-Trp) to spontaneously hypertensive rats (SHRs) reduced mean blood pressure by approximately 10 mmHg at 3 mg/kg and 40 mmHg at 15 mg/kg over 18 days of daily dosing.
The blood pressure reduction was accompanied by restoration of normal circadian blood pressure patterns, preservation of nitric oxide-dependent vasorelaxation, decreased plasma angiotensin II levels, reduced inflammatory markers, and less tissue fibrosis — all without changes in heart rate.
Why it matters
Finding food-derived peptides that can lower blood pressure could lead to functional foods or supplements for managing hypertension with fewer side effects than pharmaceutical drugs. This study is notable because IRW works through multiple mechanisms simultaneously — ACE inhibition, nitric oxide support, and anti-inflammation — which mirrors the complex pathology of hypertension better than single-target drugs.
How the study worked
Male spontaneously hypertensive rats (16–17 weeks old) were given oral IRW at either a low dose (3 mg/kg body weight) or high dose (15 mg/kg) daily for 18 days, with untreated SHRs as controls. Blood pressure and heart rate were monitored continuously via implanted telemetry devices. After the treatment period, animals were sacrificed for vascular function studies, and inflammatory markers and tissue fibrosis were measured.
What this study cannot tell us
This is an animal study using a specific rat model of hypertension (SHR), so results may not translate directly to humans. The study lasted only 18 days, so long-term effects and safety are unknown. Sample sizes per group were not specified in the abstract. The SHR model represents essential hypertension specifically and may not reflect other causes of high blood pressure. Oral bioavailability of the peptide in humans could differ significantly from rats.
How to read the evidence
This is a preclinical animal study using a well-established hypertension model. While the SHR model is a gold standard for hypertension research and telemetry monitoring is rigorous, animal results frequently don't translate to humans, placing this at a low evidence level for clinical applicability.
When this study was published
Published in 2013, this study is over a decade old. It established foundational evidence for IRW's antihypertensive potential, but readers should look for any subsequent human trials or follow-up studies.
The bigger picture
Food-derived bioactive peptides are a growing area of nutraceutical research. IRW is part of a broader class of ACE-inhibitory peptides found in milk, fish, soy, and eggs. While most remain in preclinical stages, the idea that common food proteins contain fragments that could help manage blood pressure is driving interest in functional food development as a complement to traditional pharmaceuticals.
Questions still open
- Would IRW show similar blood pressure-lowering effects in human clinical trials?
- How does IRW's oral bioavailability in humans compare to rats, and does it survive human digestion intact?
- Could IRW be developed as a functional food ingredient or supplement for mild hypertension management?
Common questions
What is IRW and where does it come from?
Can eating eggs lower blood pressure based on this study?
Read the original research
Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats.
PloS one, 8(11), e82829
Citation
Majumder, Kaustav; Chakrabarti, Subhadeep; Morton, Jude S; Panahi, Sareh; Kaufman, Susan; Davidge, Sandra T; Wu, Jianping. (2013). Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats.. PloS one, 8(11), e82829. https://doi.org/10.1371/journal.pone.0082829